Comprehensive medication guide to Paromomycin including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$5–$100 typical out-of-pocket for commercially insured patients after prior authorization approval and use of the Humatin TotalCare copay card; Tier 3–4 on most commercial plans; prior authorization almost universally required; Medicare and Medicaid coverage varies by plan.
Estimated Cash Pricing
$2,000–$8,700 estimated cash price for a typical 7-day treatment course at full list price (brand-name Humatin only; no generic available); a 100-count bottle can list for over $12,000 at some pharmacies. Eligible commercially insured patients may pay as little as $5 with the Humatin TotalCare savings card.
Medfinder Findability Score
35/100
Summarize with AI
On this page
Paromomycin is an aminoglycoside antibiotic sold under the brand name Humatin (250 mg oral capsules), manufactured by Waylis Therapeutics. It is FDA-approved to treat intestinal amebiasis caused by Entamoeba histolytica and to serve as adjunctive therapy in the management of hepatic coma (hepatic encephalopathy). As of 2026, no generic version of paromomycin is commercially available in the United States — the only generic manufacturer, Avet Pharmaceuticals, discontinued its product in September 2021.
Paromomycin is also used off-label for cryptosporidiosis, giardiasis (particularly in pregnancy), Dientamoeba fragilis infection, and tapeworm infections. Its unique characteristic is that it is poorly absorbed from the gastrointestinal tract — nearly 100% passes through unchanged — making it highly effective against intestinal parasites while limiting systemic toxicity.
Because of its limited availability and lack of generic competition, paromomycin can be difficult to find at retail pharmacies. Patients typically need to contact hospital pharmacies, specialty pharmacies, or independent pharmacies to fill a prescription.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Paromomycin works by binding irreversibly to the 30S ribosomal subunit of bacterial and parasitic cells. The ribosome is the cellular machine responsible for building proteins by reading the genetic code (mRNA). When paromomycin latches onto the 30S subunit, it causes the ribosome to misread the mRNA sequence, resulting in the production of abnormal, nonfunctional proteins. Without functional proteins, bacteria and parasites cannot survive — making paromomycin bactericidal (organism-killing) rather than simply bacteriostatic (growth-inhibiting).
Human cells use a differently structured ribosome (60S + 40S subunits vs. the 50S + 30S found in bacteria), which is why paromomycin selectively targets pathogens rather than human cells. Combined with its near-complete lack of GI absorption, paromomycin achieves high intestinal concentrations that kill parasites in the gut lumen while minimizing systemic exposure and side effects.
This property makes paromomycin a 'luminal agent' — it is active only against organisms living in the intestinal lumen. It cannot treat invasive amebiasis (where E. histolytica has spread to tissue or liver) and must be paired with a tissue amebicide like metronidazole or tinidazole for such cases.
250 mg — capsule
Brand-name Humatin (Waylis Therapeutics). Oral capsule, taken with meals. Available in 100-count bottles. NDC 80725-0250-01.
Paromomycin is one of the most difficult medications to fill at a standard retail pharmacy in the United States. The only generic manufacturer discontinued its product in September 2021, leaving brand-name Humatin (Waylis Therapeutics) as the sole commercially available option. Most chain pharmacies — CVS, Walgreens, Walmart, Rite Aid — do not stock Humatin routinely due to low prescription volume and high unit cost.
Hospital-affiliated pharmacies and specialty pharmacies are the most reliable sources. Some independent pharmacies are able to special-order Humatin from their wholesaler, though this typically takes 5–7 business days for retail chains or 1–3 days for specialty/hospital pharmacies.
The fastest way to find a pharmacy with paromomycin in stock is to use medfinder — a paid service that calls pharmacies in your area and identifies which ones can fill your prescription, with results texted directly to you.
Paromomycin is not a controlled substance, so any licensed healthcare provider with prescribing authority can write a prescription. However, because the conditions it treats (intestinal parasitic infections, hepatic encephalopathy) require laboratory confirmation and specialized diagnosis, prescriptions most commonly come from specialists. Prior authorization from insurance is almost always required.
Infectious disease specialists
Travel medicine physicians
Gastroenterologists and hepatologists
Primary care physicians (PCPs)
Nurse practitioners and physician assistants (under supervision)
OB-GYNs and maternal-fetal medicine specialists (for use in pregnancy)
Paromomycin can be prescribed via telehealth since it is a non-controlled antibiotic. However, diagnosis of intestinal parasitic infections requires stool testing (O&P or PCR), which must be completed before or concurrent with prescribing. Telehealth is most appropriate for follow-up care or prescription renewal when the diagnosis has already been established.
No. Paromomycin is not a controlled substance and is not scheduled by the DEA. It does not have abuse or dependence potential, and there are no special prescribing restrictions beyond those that apply to all prescription drugs. Any licensed prescriber with prescribing authority can write a prescription for paromomycin (Humatin), including via telehealth. Prescriptions can be transmitted electronically, by fax, or by phone.
While paromomycin itself has no controlled substance restrictions, insurance prior authorization is commonly required before a pharmacy will dispense it. Patients should expect their prescriber to initiate a prior authorization request with their insurance company at the time of prescribing.
Most side effects of paromomycin are gastrointestinal and tend to occur at higher doses (above 3 g/day):
Nausea
Abdominal cramps
Diarrhea (especially at doses >3 g/day)
Heartburn or vomiting
Nephrotoxicity (kidney damage): decreased urination, swelling, unusual fatigue
Ototoxicity (hearing/balance damage): ringing in ears, hearing loss, dizziness
Neuromuscular blockade (rare): muscle weakness, breathing difficulty
Superinfection: new or worsening symptoms during treatment (fungal overgrowth)
Know what you need? Skip the search.
Iodoquinol (Yodoxin)
Most direct alternative to paromomycin as a luminal amebicide. Used to eradicate E. histolytica intestinal cysts. Dose: 650 mg TID × 20 days. Contains iodine — avoid in iodine hypersensitivity or thyroid disease.
Metronidazole (Flagyl)
First-line treatment for invasive/symptomatic amebiasis. Tissue amebicide, not a luminal agent — does not replace paromomycin for cyst eradication. Widely available as a generic.
Tinidazole (Tindamax)
Nitroimidazole preferred over metronidazole in some guidelines for amebiasis; shorter course, better tolerated. Also a tissue amebicide requiring follow-up luminal agent. Generic available.
Nitazoxanide (Alinia)
Broad antiparasitic active against both luminal and invasive forms of E. histolytica; first-line for cryptosporidiosis and giardiasis. May eliminate need for combination therapy in some cases.
Prefer Paromomycin? We can find it.
Loop diuretics (furosemide, bumetanide)
majorAdditive ototoxicity and nephrotoxicity — avoid concurrent use if possible
Neuromuscular blocking agents (atracurium, succinylcholine)
majorSynergistic risk of apnea — avoid combination; notify anesthesiologist if perioperative use
BCG vaccine (live)
majorParomomycin can kill live BCG vaccine bacteria — contraindicated; wait until antibiotic course is complete
Warfarin
moderateSmall increase in anticoagulant effect via reduced intestinal vitamin K production; monitor INR
Oral contraceptives
moderateMay slightly reduce efficacy by altering gut flora; backup contraception recommended
Oral methotrexate
moderateMay reduce methotrexate GI absorption via inhibition of bowel flora; notify rheumatologist/oncologist
Voclosporin
moderateAdditive nephrotoxicity risk; monitor kidney function
Paromomycin (Humatin) is a clinically important antiparasitic drug that plays a nearly irreplaceable role as a luminal amebicide in the treatment of intestinal amebiasis. It is also one of the safest antiparasitic options in pregnancy due to its minimal systemic absorption. Despite its importance, it remains one of the hardest prescription medications to fill in the United States, with no generic available and only a single manufacturer supplying the market.
For patients prescribed paromomycin, the path to treatment requires navigating pharmacy availability, insurance prior authorization, and cost management — often simultaneously. The Humatin TotalCare copay savings card can reduce cost to as little as $5 per fill for commercially insured patients, and a separate patient assistance program is available for uninsured patients without Medicare or TRICARE.
If you're struggling to find paromomycin at a pharmacy near you, medfinder is a paid service that calls pharmacies in your area and identifies which ones have it in stock and can fill your prescription — with results sent by text.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards